High prevalence of hospital malnutrition associated with poor ... - 14 December 2020 13:00

BAD HOMBURG, Germany, Dec. 14, 2020 /PRNewswire-AsiaNet/ -- Hospital malnutrition is documented in many observational studies from the United States, Europe, and Latin America. A recently published literature review found that malnutrition is highly prevalent across different hospital patient groups in 11 ...

  The EspeRare Foundation and Pierre Fabre join forces to develo... - 14 December 2020 09:00

GENEVA and CASTRES, France, Dec. 14, 2020 /PRNewswire-AsiaNet/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked Hypohidr...

  AGS Health Recognized in KLAS(R) Report - 12 December 2020 03:49

OLYPHANT, Pa., Dec. 11, 2020 /PRNewswire-AsiaNet/ -- -- "Outsourced Coding 2020, Which Firms Deliver Quality and Value" AGS Health, a leader in revenue cycle management services for major healthcare providers across the U.S. today announced it has been recognized by KLAS(R) Research as a "consist...

  Catalent Appoints Nakaya Matsumaru as General Manager of its N... - 11 December 2020 13:30

SOMERSET, N.J., Dec. 11, 2020 /PRNewswire-AsiaNet/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakay...

  DETECT program studies validate clinical relevance of CTC HER2... - 11 December 2020 01:12

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020 /PRNewswire-AsiaNet/ -- - Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome Me...

  INOVIO and Advaccine Announce First Dosing of Subject in Phase... - 11 December 2020 00:00

PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire-AsiaNet/ -- -- Dosing marks a key milestone for INO-4800 in China and its second Phase 2 clinical trial globally INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...

  Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Con... - 10 December 2020 16:22

SYDNEY, Dec. 10, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clini...

  iHerb Announces Exciting New Ways to Earn with iHerb's Rewards... - 10 December 2020 06:33

PASADENA, Calif., Dec. 10, 2020 /PRNewswire-AsiaNet/ -- iHerb, a global leader in health and beauty e-commerce, announces ground-breaking new updates to their Rewards program with even more exciting ways to earn Rewards. Logo - https://mma.prnewswire.com/media/1361351/UGCI_Review_Rewards_Talking_Po...

  New Global Pooled Analysis Supports Clinical Utility of Circul... - 10 December 2020 02:04

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., December 9, 2020, /PRNewswire-AsiaNet/-- Menarini Silicon Biosystems [http://www.siliconbiosystems.com/ ], a pioneer of liquid biopsy technology, today announced the results of a pooled analysis of 14 clinical trials on the relevance of circulating tumor cell (CTC) count to predict both ...

  INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Tr... - 10 December 2020 00:00

PLYMOUTH MEETING, Pa., Dec. 9, 2020 /PRNewswire/ -- -- DNA immunotherapy candidate VGX-3100 demonstrated resolution of HPV-16/18-associated precancerous anal lesions in 50% of treated patients six months after treatment -- Current standard of care for anal dysplasia typically requires surgical ...